Alignment Healthcare (NASDAQ:ALHC) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says

Alignment Healthcare (NASDAQ:ALHC) had its target price raised by equities researchers at Stifel Nicolaus from $16.00 to $18.00 in a research report issued on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective points to a potential upside of 14.72% from the company’s previous close.

A number of other equities analysts have also weighed in on ALHC. William Blair reissued an “outperform” rating on shares of Alignment Healthcare in a research report on Friday. Barclays boosted their target price on Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a research report on Friday. Finally, Stephens reissued an “overweight” rating and issued a $17.00 target price on shares of Alignment Healthcare in a research report on Monday, February 24th. One analyst has rated the stock with a sell rating, two have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Alignment Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $12.25.

Alignment Healthcare Price Performance

ALHC opened at $15.69 on Friday. The stock has a 50-day moving average price of $13.50 and a 200-day moving average price of $11.97. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The firm has a market cap of $3.01 billion, a PE ratio of -20.38 and a beta of 1.50. Alignment Healthcare has a 1 year low of $4.46 and a 1 year high of $15.85.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, CEO John E. Kao sold 90,000 shares of the business’s stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $11.65, for a total transaction of $1,048,500.00. Following the completion of the sale, the chief executive officer now directly owns 2,363,100 shares in the company, valued at $27,530,115. The trade was a 3.67 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Sebastian Burzacchi sold 8,550 shares of the business’s stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $11.26, for a total value of $96,273.00. Following the sale, the chief operating officer now owns 217,395 shares of the company’s stock, valued at approximately $2,447,867.70. This represents a 3.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 441,002 shares of company stock worth $5,772,726 in the last three months. 6.60% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ALHC. Creative Planning grew its stake in shares of Alignment Healthcare by 20.0% during the 3rd quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after acquiring an additional 2,072 shares during the period. Principal Financial Group Inc. grew its stake in shares of Alignment Healthcare by 1,335.1% during the 3rd quarter. Principal Financial Group Inc. now owns 194,043 shares of the company’s stock valued at $2,294,000 after acquiring an additional 180,522 shares during the period. Royce & Associates LP bought a new position in shares of Alignment Healthcare during the 3rd quarter valued at approximately $3,782,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Alignment Healthcare during the 3rd quarter valued at approximately $131,000. Finally, Intech Investment Management LLC bought a new position in shares of Alignment Healthcare during the 3rd quarter valued at approximately $315,000. 86.19% of the stock is currently owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.